Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment

Psychiatric Genetics

Volumn 18, Issue 2, 2008, Pages 64-72

  Chetcuti, Albert ^a,b,c,d   Adams, Linda J ^a,b   Mitchell, Philip B ^d,e   Schofield, Peter R ^a,b,c,d  

^a SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e BLACK DOG INSTITUTE   (Australia)

Author keywords

Animal models; Bipolar disorder; Lithium; Microarray; Quantitative PCR

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA 1 POLYPEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; LITHIUM CHLORIDE; MESSENGER RNA; METALLOTHIONEIN III; POLYPEPTIDE; PROTEASOME; PROTEASOME SUBUNIT BETA TYPE 5; TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2; ATP1A1 PROTEIN, HUMAN; ELONGIN; GNB1 PROTEIN, MOUSE; GROWTH INHIBITOR; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NERVE PROTEIN; PSMB5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BIPOLAR DISORDER; BRAIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DOWN REGULATION; DRUG EFFECT; ENZYME REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; MALE; MICROARRAY ANALYSIS; MOUSE; NEUROMODULATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA ANALYSIS; TREATMENT DURATION; ANIMAL; BIOSYNTHESIS; BRAIN LEVEL; C57BL MOUSE; DNA MICROARRAY; GENETICS;

ANIMALIA; MUS;

ANIMALS; BRAIN CHEMISTRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HETEROTRIMERIC GTP-BINDING PROTEINS; LITHIUM CHLORIDE; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRANSCRIPTION FACTORS;

EID: 42949162144     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3282fb0051     Document Type: Article

References (55)

1. Agid O, Seeman P, Kapur S (2006). The 'delayed onset' of antipsychotic actionan idea whose time has come and gone. J Psychiatry Neurosci 31:93-100.
2. Bai O, Zhang H, Li XM (2004). Antipsychotic drugs clozapine and olanzapine upregulate Bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010:81-86.
3. Barcroft LC, Moseley AE, Lingrelc JB, Watson AJ (2003). Deletion of the Na/K-ATPase a1-subunit gene (Atp1a1) does not prevent cavitation of the preimplantation mouse embryo. Mech Dev 121:417-426.
4. Basselin M, Chang L, Seemann R, Bell JM, Rapoport SI (2005). Chronic lithium administration to rats selectively modifies 5-HT(2A/2C) receptor-mediated brain signaling via arachidonic acid. Neuropsychopharmacology 30:461-472.
5. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci 101:5099-5104.
6. Bosetti F, Seemann R, Bell JM, Zahorchak R, Friedman E, Rapoport SI, Manickam P (2002). Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull 57:205-209.
7. Bradsher JN, Jackson KW, Conaway RC, Conaway JW (1993). RNA polymerase II transcription factor SIII 1. Identification, purification, and properties. J Biol Chem 268:25587-25593.
8. Bro C, Regenberg B, Lagniel G, Labarre J, Montero-Lomeli M, Nielsen J (2003). Transcriptional, proteomic, and metabolic responses to lithium in galactose-grown yeast cells. J Biol Chem 278:32141-32149.
9. Cade JF (1949). Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349-352.
10. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein Bcl-2 in the CNS. J Neurochem 72:879-882.
11. Chetcuti A, Adams LJ, Mitchell PB, Schofield PR (2006). Altered gene expression in mice treated with the mood stabilizer sodium valproate. Int J Neuropsychopharmacol 9:267-276.
12. Constantinou C, Bolaris S, Valcana T, Margarity M (2005). Acute LiCl-treatment affects the cytoplasmic T4 availability and the expression pattern of thyroid hormone receptors in adult rat cerebral hemispheres. Neurosci Lett 51:235-241.
13. Demasi M, Davies KJA (2003). Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism. FEBS Lett 542:89-94.
14. Duan DR, Pause A, Burgess WH, Aso T, Chen DY, Garrett KP, et al. (1995). Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402-1406.
15. Gandarias JMd, Acebes I, Echevarria E, Vegas L, Abecia LC, Casis L (2000). Lithium alters mu-opioid receptor expression in the rat brain. Neurosci Lett 279:9-12.
16. Giralt M, Carrasco J, Penkowa M, Morcillo MA, Santamarý J, Campbell IL, Hidalgo J (2001). Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain. Exp Neurol 168:334-346.
17. Glickman MH, Ciechanover A (2002). The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373-428.
18. Hidalgo J, Aschner M, Zatta P, Vasak M (2001). Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bul 55:133-145.
19. Holtz WA, O'Malley KL (2003). Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278:19367-19377.
20. Hooks MS, Juncoq JL, Justice JB, Meiergerd SM, Povlock SL, Schenk J, Kalivasl PW (1994). Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J Neurosci 14:6144-6152.
21. Hua LV, Green M, Warsh JJ, Li PP (2000). Lithium regulation of aldolase A expression in the rat frontal cortex: identification by differential display. Biol Psychiatry 48:58-64.
22. Iliopoulos O, Levy AP, Jian C, Kaelin WG, Goldberg MA (1996). Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A 93:10595-10599.
23. Iriea Y, Itokazua N, Anjikia N, Ishigea A, Watanabea K, Keung WM (2004). Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus. Brain Res 1011:243-246.
24. Iwamoto K, Bundo M, Kato T (2004). Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14:241-253.
25. Jope RS (2003). Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24:441-443.
26. Kamura T, Sato S, Haque D, Liu L, Kaelin WG, Conaway RC, Conaway JW (1998). The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12:3872-3881.
27. Kitanaka N, Kitanaka J, Walther D, Wang XB, Uhl GR (2003). Comparative interstrain sequence analysis of the putative regulatory region of murine psychostimulant-regulated gene GNB1 (G protein b1 subunit gene). DNA Seq 14:257-263.
28. Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. PNAS 93:8455-8459.
29. Kopnisky KL, Chalecka-Franaszek E, Gonzalez-Zulueta M, Chuang DM (2003). Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities. Neuroscience 116:425-435.
30. Laursen UH, Pihakaski-Maunsbach K, Kwon TH, Jensen EO, Nielsen S, Maunsbach AB (2004). Changes of rat kidney AQP2 and Na,K-ATPase mRNA expression in lithium-induced nephrogenic diabetes insipidus. Nephron Exp Nephrol 97:e1-e16.
31. Lingrel J, Moseley A, Dostanic I, Cougnon M, He S, James P, et al. (2003). Functional roles of the alpha isoforms of the Na,K-ATPase. Ann NY Acad Sci 986:354-359.
32. Lingrel JB, Kuntzweiler T (1994). Na +,K + -ATPase. J Biol Chem 269:19659-19662.
33. Maayan R, Shaltiel G, Poyurovsky M, Ramadan E, Morad O, Nechmad A, et al. (2004). Chronic lithium treatment affects rat brain and serum dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEA-S) levels. Int J Neuropsychopharmacol 7:71-75.
34. Manji HK, Lenox RH (2000). Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 48:518-530.
35. Manji HK, Moore GJ, Chen G (2001). Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry 178:s107-s119.
36. Mitchell PB (2001). Therapeutic drug monitoring of psychotropic medications. Br J Pharmacol 52:45S-54S.
37. Mitchell PB, Hadzi-Pavlovic D (1999). John Cade and the discovery of lithium treatment for manic depressive illness. Med J Aust 171:262.
38. Mitchell PB, Manji HK, Chen G, Jolkovsky L, Smith-Jackson E, Denicoff K, et al. (1997). High levels of GSA in platelets of euthymic patients with bipolar affective disorder. Am J Psychiatry 154:218-223.
39. O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH (2003). Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain. Eur Neuropsychopharmacol 13:199-207.
40. Pardo R, Andreolotti AG, Ramos B, Picatoste F, Claro E (2003). Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms. J Neurochem 87:417-426.
41. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ (2003). Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4:26.
42. Sarno PD, Li X, Jope RS (2002). Regulation of Akt and glycogen synthase kinase-3beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:1158-1164.
43. Semba J, Watanabe H, Suhara T, Akanuma N (2000). Chronic lithium chloride injection increases glucocorticoid receptor but not mineralocorticoid receptor mRNA expression in rat brain. Neurosci Res 38:313-319.
44. Spencer CM, Houpt TA (2001). Dynamics of c-fos and ICER mRNA expression in rat forebrain following lithium chloride injection. Brain Res Mol Brain Res 93:113-126.
45. Su Y, Ryder J, Li B, Wu X, Fox N, Solenberg P, et al. (2004). Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry 43:6899-6908.
46. Takahashi Y, Washiyama K, Kobayashi T, Hayashi S (2006). Gene expression in the brain from fluoxetine-injected mouse using DNA microarray. Ann NY Acad Sci 1074:42-51.
47. Uchida Y, Ihara Y, Tomonaga M (1988). Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats. Biochem Biophys Res Commun 150:1263-1267.
48. Vaden DL, Ding D, Peterson B, Greenberg ML (2001). Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J Biol Chem 276:15466-15471.
49. Vasconcellos AP, Tabajara AS, Ferrari C, Rocha E, Dalmaz C (2003). Effect of chronic stress on spatial memory in rats is attenuated by lithium treatment. Physiol Behav 79:143-149.
50. Wang JF, Bown C, Young LT (1999). Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78. Mol Pharmacol 55:521-527.
51. Wang JF, Chen B, Young LT (1999). Identification of a novel lithium regulated gene in rat brain. Brain Res Mol Brain Res 70:66-73.
52. Wang XB, Funada M, Imai Y, Revay RS, Ujike H, Vandenbergh DJ, Uhl GR (1997). rGb1: a psychostimulant-regulated gene essential for establishing cocaine sensitization. J Neurosci 17:5993-6000.
53. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS (2004). Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci 101:3973-3978.
54. Yuan P, Chen G, Manji HK (1999). Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo. J Neurochem 73:2299-2309.
55. Zhang WV, Jullig M, Connolly AR, Stott NS (2005). Early gene response in lithium chloride induced apoptosis. Apoptosis 10:75-90.